TherapeuticsMD, Inc. (TXMD) Earnings History
Profitable32 years of earnings data (1994–2025) · Positive TTM net income
Loading earnings history...
TherapeuticsMD, Inc. (TXMD) Earnings Overview
As of June 22, 2026, TherapeuticsMD, Inc. (TXMD) reported trailing twelve-month net income of $179,000, reflecting +74.1% year-over-year growth. The company earned $0.02 per diluted share over the past four quarters, with a net profit margin of -18.8%.
Looking at the long-term picture, TXMD's historical earnings data spans multiple years. The company achieved its highest annual net income of $112M in fiscal 2022.
TherapeuticsMD, Inc. maintains positive profitability with a gross margin of 100.0%, operating margin of -139.4%, and net margin of -18.8%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including PGNY ($68M net income, 4.5% margin), DARE (-$12M net income, -1300.7% margin), ANIP ($90M net income, 8.9% margin), TXMD has room to improve margins relative to the peer group. Compare TXMD vs PGNY →
TXMD Earnings vs Peers
Earnings metrics vs comparable public companies
TXMD Historical Earnings Data (1994–2025)
32 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $-569,000 | +73.9% | -$4M | $-0.05 | -18.8% | -139.4% |
| 2024 | -$2M | +78.8% | -$5M | $-0.19 | -123.9% | -270.3% |
| 2023 | -$10M | -109.2% | -$9M | $-0.74 | -789.4% | -654.6% |
| 2022 | $112M | +165.0% | $1M | $-10.35 | 160.1% | 1.7% |
| 2021 | -$172M | +6.1% | -$80M | $-25.83 | -6700.9% | -3092.8% |
| 2020 | -$184M | -4.2% | -$156M | $-38.58 | -282.9% | -239.8% |
| 2019 | -$176M | -32.8% | -$151M | $-39.79 | -354.8% | -304.6% |
| 2018 | -$133M | -72.4% | -$130M | $-29.47 | -823.7% | -808.8% |
| 2017 | -$77M | +14.4% | -$78M | $-18.71 | -458.5% | -462.7% |
| 2016 | -$90M | -5.6% | -$90M | $-22.92 | -464.3% | -466.3% |
| 2015 | -$85M | -56.9% | -$85M | $-24.56 | -422.4% | -422.9% |
| 2014 | -$54M | -90.8% | -$54M | $-18.11 | -360.8% | -359.6% |
| 2013 | -$28M | +19.1% | -$26M | $-11.14 | -323.8% | -294.1% |
| 2012 | -$35M | -172.0% | -$16M | $-19.16 | -919.9% | -423.0% |
| 2011 | -$13M | -1757.0% | -$5M | $-10.33 | -618.4% | -259.9% |
| 2010 | $-695,375 | +58.0% | $-467,959 | $-90.82 | -1442.2% | -970.5% |
| 2009 | -$2M | -318.3% | -$2M | $-1139.49 | -15654.7% | -15570.9% |
| 2008 | $-395,553 | -331.9% | $-395,553 | $-648.45 | - | - |
| 2007 | $170,542 | -54.3% | $-93,743 | $550.14 | - | - |
| 2006 | $373,015 | +28.7% | $488,883 | $-470.08 | 37.1% | 48.6% |
| 2005 | $289,887 | +104.0% | $348,992 | $-83.33 | 31.0% | 37.3% |
| 2004 | $142,116 | +51.0% | $196,758 | $-216.67 | 22.9% | 31.6% |
| 2003 | $94,109 | -4.9% | $104,109 | $16.84 | 21.5% | 23.8% |
| 2002 | $98,912 | +60.7% | $98,912 | $74.00 | 34.5% | 34.5% |
| 2001 | $61,535 | -53.3% | $61,535 | $100.11 | 18.5% | 18.5% |
| 2000 | $131,668 | +959.3% | $131,668 | $21.17 | 35.8% | 35.8% |
| 1999 | $12,430 | +179.8% | $15,644 | $-4.98 | 5.8% | 7.3% |
| 1998 | $-15,582 | -22.3% | $-4,837 | $-50.43 | -8.0% | -2.5% |
| 1997 | $-12,738 | -117.3% | $49,262 | $-41.22 | -6.6% | 25.5% |
| 1996 | $73,793 | +134.2% | $74,463 | $238.81 | 30.2% | 30.5% |
| 1995 | $31,511 | -7.8% | $36,103 | $101.98 | 16.1% | 18.4% |
| 1994 | $34,183 | - | $34,183 | $110.62 | 17.4% | 17.4% |
Download Data
Export TXMD earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
32+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
TXMD — Frequently Asked Questions
Quick answers to the most common questions about buying TXMD stock.
What is TXMD earnings per share (EPS)?
TXMD trailing twelve-month (TTM) diluted EPS is $0.02, reflecting +74.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1994 to 2025 is available in the table on this page.
What is TherapeuticsMD, Inc.'s net income?
TherapeuticsMD, Inc. (TXMD) trailing twelve-month net income is $179000.00 as of 2025. Earnings grew +74.1% year-over-year.
Is TXMD profitable?
Yes, TXMD is profitable with a TTM net income of $179000.00 and a net profit margin of -18.8%.
What is TXMD's earnings growth rate?
TXMD compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1994 to 2025.
What are TXMD's profit margins?
TherapeuticsMD, Inc. net profit margin is -18.8%, operating margin is -139.4%, and gross margin is +100.0%. Below-average margins reflect competitive or cost pressures. Return on Equity is -2.1%.
Is TXMD growing earnings?
Yes, TXMD earnings are accelerating — EPS growth of +74.1% exceeds the 5-year CAGR of N/A. TTM net income reached $179000.00. Earnings momentum is strengthening.
What was TXMD's best earnings year?
TherapeuticsMD, Inc.'s highest annual net income on record is $112M, achieved in fiscal year 2022. Earnings history on this page spans 1994 to 2025 and includes all annual and quarterly figures.
What were TXMD's earnings last quarter?
TXMD's most recent reported quarter was Q1 2026. Net income was $95000.00 with diluted EPS of $0.01. For a full breakdown of all quarters, see the quarterly earnings table on this page.